Efficacy and Safety of JS016 in Patients With SARS-CoV-2 Infection (COVID-19)

NCT04931238 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
SARS-CoV-2

Interventions

DRUG: JS016

Sponsor

Peking Union Medical College Hospital